Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mutaflor as Adjuvant Therapy in Type 2 Diabetes Mellitus
NCT02144948Phase 3Completed
- Sponsor
- GWT-TUD
- Start
- Aug 2014
- Primary completion
- Jan 2016
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
A Phase 3 trial of escherichia coli nissle 1917 in type 2 diabetes mellitus (T2DM), sponsored by GWT-TUD. Started Aug 2014; status: completed.
02
Drugs
escherichia coli nissle 1917
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02144948.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02144948.